Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
Vesting of conditional share awards under the
GlaxoSmithKline Share Value Plan
This notification sets out the vesting of awards over Ordinary Shares and American Depositary Shares (ADS) in GlaxoSmithKline plc, made in 2010 under the GlaxoSmithKline Share Value Plan (SVP), which were conditional on continued employment with the GlaxoSmithKline group.
The three-year vesting period for the 2010 SVP awards, which commenced on 23 February 2010, has now ended. The awards made to the connected persons of a Director and of a Person Discharging Managerial Responsibility (PDMR) vested on 1 March 2013 and details are given in the table below.
Name of Director / PDMR |
Name of Connected person |
Number of ADS vested |
Number of Ordinary Shares vested |
Mr P Thomson |
Mrs K Thomson |
|
837 |
Dr M Slaoui* |
Mrs K Slaoui |
640 |
|
* Denotes an Executive Director
The Company and the above individuals were advised of these transactions on 1 March 2013.
The fair market values of an Ordinary Share and of an ADS of GlaxoSmithKline plc at the point of vesting on 1 March 2013 were £14.55 and US$44.03 respectively.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
V A Whyte
Company Secretary
4 March 2013